Neurode, a Sydney-based startup, is taking a unique approach to treating Attention Deficit Hyperactivity Disorder (ADHD). They've developed a wearable headband that uses light electrical stimulation to target the prefrontal cortex of the brain, aiming to improve focus and manage ADHD symptoms.
Neurode's headband utilizes transcranial direct current stimulation (tDCS) technology. It delivers a gentle electrical current to the prefrontal cortex, a region of the brain associated with executive function and attention control. This stimulation aims to modulate brain activity, potentially leading to improved focus and reduced ADHD symptoms.
Nathalie Gouailhardou, a neuroscientist and ADHD patient, founded Neurode. Frustrated with the limitations and side effects of traditional ADHD medication, she sought a non-invasive approach.
Neurode has secured $3.5 million in pre-seed funding, led by Khosla Ventures, to support clinical trials and further development of its headband. The company is currently conducting clinical trials to validate the effectiveness and safety of its device.
Neurode believes its headband technology has the potential to extend beyond ADHD treatment. The company is exploring the application of its wearable to address other conditions like age-related cognitive decline and depression.
Neurode's mission is to provide a safe and effective non-invasive treatment option for individuals with ADHD. They aim to empower individuals with ADHD to manage their symptoms and live fulfilling lives.
Neurode's innovative approach to ADHD treatment represents a significant advancement in the field. Their wearable headband has the potential to offer a personalized and non-invasive alternative to traditional medication, providing hope for millions of individuals seeking effective management of their symptoms.
Ask anything...